Who hasn’t heard of Johnson & Johnson? For sure most Americans have used one or two of its products. After all Johnson & Johnson (J&J) is an American company that has been manufacturing healthcare products for more than 130 years.
The company’s headquarters is located in New Brunswick, New Jersey. It’s a huge multinational company, running more than 250 subsidiaries. Sixty countries around the world benefit from J&J’s local operations, providing employment to 134,000 people. Johnson & Johnson products are available in more than 175 countries worldwide.
Largest in the world
Around the world, Johnson & Johnson is recognized as the most diversified and largest healthcare company. J&J has three business divisions: pharmaceutical, packaged consumer goods and medical devices.
The consumer goods division manufactures the largest range of health products from oral care to baby care to beauty, healing and health.
J&J’s medical devices division comprises several companies, which have developed and manufactured various patient- and physician-centric solutions, programs and products for more than 100 years. The division has companies producing medical devices for eye health, medical specialty business, cardiovascular diseases, orthopedic and surgical fields.
Johnson & Johnson medical devices
The company, started by brothers Robert Wood Johnson, Edward Mead Johnson and James Wood Johnson, first developed a line of ready to use surgical dressings. Their first products already contained a logo that is similar to James Wood Johnson’s signature. With their corporate mission to create new and value-oriented products to help people live healthy lives, Johnson & Johnson acquired several companies through the years to develop products for consumers, patients, healthcare systems and healthcare professionals worldwide.
Throughout the history of its medical devices sector, Johnson & Johnson has managed to develop new markets, create solid partnerships and deliver advanced products. The company’s internal research and development capability is outstanding, supported by its business development group, J&J innovation group and its Office of Medical Science and Technology.
About nine companies make up the Johnson & Johnson’s medical devices division, which is active in the following areas:
- Aesthetics – Mentor, Ethicon
- General surgery – Codman Neuro, Ethicon
- Hernia surgery – Ethicon
- Urologic surgery – Ethicon
- Bariatric surgery for Obesity – Ethicon
- Arrhythmias – Biosense Webster
- Cardiovascular diseases – Biosense Webster
- Ear, Nose, and Throat conditions – Acclarent
- Diabetes care – Animas Corporation, LifeScan
- Insulin delivery devices – Animas
- Surgical instruments and infection prevention – Advanced Sterilization Products
- Self-Measured blood glucose monitors – LifeScan
- Vision care – Vistakon ®
- Neurovascular disease – DePuy Synthes, Codman Neuro
- Orthopedics – DePuy Synthes (power tools, sports medicine, spine, trauma, joint reconstruction
Helping the world heal and live healthily
There are many manufacturers of medical devices around the world, as expected, as there are so many products, devices and equipment needed for various illnesses and medical conditions. The medical device industry is huge. It was worth $521.2 billion in 2017 and by 2022, it is expected to reach $674.5 billion. In 2017, one of its segments, drug delivery devices, hit $207.8 billion. By 2022, this specific segment alone is expected to be worth $243.4 billion. In 2017, the cardiovascular device business was worth $29.7 billion. In 2022 it is expected to attain $43.5 billion in revenues.
Based on the market share, Johnson & Johnson’s medical devices division ranked second in 2018, with a market share of 5.24%. Its 2018 revenues were $27.0 billion. Although there was an increase of 1.5% over the 2017 revenues, it reflected the sale of the glucose monitoring business of LifeSpan. However, Johnson & Johnson acquired Medical Enterprises Distribution’s assets and other businesses, such as Auris Health, Orthotaxy and Emerging Implant Technologies.
As mentioned, Johnson & Johnson medical devices are sold in 175 countries worldwide. Its products are used in hospitals, clinics and other healthcare facilities in various countries. The company supplies surgical instruments and systems for surgery, including sutures, monitoring systems for diabetes and cardiovascular diseases and more. Johnson & Johnson medical devices companies’ research and development center finds solutions and programs for surgical needs that are not yet met.
Johnson & Johnson continues to expand worldwide because the company has a clear vision of where it is going and what it wants to do. It carefully selects the companies that it wants to acquire in order to respond to the growing needs of the people and countries the company serves.
The company has a very robust and strong research and development center that continuously explores ways for global expansion. It finds and develops medical device products that their local markets require. The company is proving successful in their approach. More than half of the company’s revenues are from markets outside its home country. It is exploring emerging markets as well, which has seen new growth in sales. According to the company, the sales from the emerging markets account for 23% of the entire sales of Johnson and Johnson.
Gary Pruden, who is Johnson & Johnson’s Global Surgery Group world chairman, a large percentage of the one million surgical procedures performed daily worldwide, use the technologies developed by the Global Surgery Group of J&J.
Creating products appropriate to different markets
The medical device group of companies of Johnson & Johnson continues to identify the needs of the local markets and create innovative market-appropriate solutions that are accessible and affordable.
For example, for the emerging markets, it sells the blood glucose monitoring system called OneTouch® SelectSimple®. Its operating system is simple and the system is affordable. For the same markets, the group has an infection prevention solution called ENDOCLENS-NSX™. The product is available in Malaysia, Colombia, Chile, India, Russia, China, and Brazil, parts of the Middle East, South Africa and other countries, except for Europe.
The group invests heavily on R&D to respond to the needs of its global market, creating customized portfolio for several emerging markets, including the Asia Pacific region. It includes local sourcing of manufacturers and R&D teams. It likewise creates professional education and enhanced training for healthcare providers. Their solutions for local market needs respond to the clinical and economic needs of its consumers.
With the increasing number of diabetics in emerging markets, Johnson and Johnson medical device group offers OneTouch® Verio® Glucose testing platform. It helps diabetics to manage their illness with this device. It functions by alerting the patient and displaying the high and low patters of glucose levels. J&J’s Calibra (recently purchased by CeQur) created an insulin patch that diabetic patients can wear to deliver the correct basal insulin dose at mealtime.
Johnson & Johnson’s medical device portfolio includes wound closure devices that are matched to the wound healing needs of each tissue type. The first FDA-cleared adhesive for wound closure is J&J’s Dermabond®.
Comprehensive range of products
Johnson & Johnson’s medical devices group is the most comprehensive in the world. The industry is estimated to be worth over $370 billion. The company continues to find and provide solutions for the needs of healthcare practitioners and patients worldwide. It moves out of markets that are already saturated and explore markets that are in need of better solutions and programs. Aside from the medical devices needed by hospitals, J&J is focusing on specialty surgery, cardiovascular, orthopedics and general surgery categories.
The expert and complementary combination of product range, talents, capabilities and geographic presence makes Johnson & Johnson’s medical devices group a global healthcare powerhouse.
Its size and the expertise of its management teams to adapt entrepreneurial values make the entire company work seamlessly. The problem-solving skills of its R&D group allow the company to analyze the problems of different markets and provide solutions that accelerate the company’s growth.
Moreover, the company finds ways to connect to the public on a more personal level by providing financial support for medical missions worldwide, such as Operation Smile. The company sends employees to join the missions. It has a Johnson & Johnson Institute where surgeons can receive advanced training and develops programs in various aspects, such as operational efficiency, patient engagement and control of infection risks.
High quality medical translation
Medical translation is a sector where a high degree of precision and accuracy is critical. Because it involves human lives, there is no room for even the simplest of error in medical translation. It requires the professionalism and experience of subject matter experts to ensure that the right medical terminology for the specific procedure or branch of medicine is used. The language of the medical translation is vital as well, as some translations will be used by patients while others will be for the information of professionals in the field. Thus, it is important to work with a professional translation company that has a wide range of medical translation and medical interpreting experience like Day Translations, Inc. We have the right subject matter experts who natively speak the languages you require. They live in-country, ensuring that they have an in-depth knowledge of the culture and the language. Trust Day Translations to deliver the most accurate medical translation whatever size the project is. We are open 24/7, every day of the year so you can contact us through 1-800-969-6853 or email us at Contact us anytime.
Image Copyright: Yuriy Klochan / 123RF Stock Photo